|
Betaine:homocysteine methyltransferase--a new assay for the liver enzyme and its absence from human skin fibroblasts and peripheral blood lymphocytes. |
|
Dimethylglycine and chemically related amines tested for mutagenicity under potential nitrosation conditions. |
|
[Cholagogic effect of trimethylglycine in normal animals of different ages and in experimental atherosclerosis] |
|
[Corrective effect of trimethylglycine on the nicotinamide coenzyme and adenine nucleotide content of the tissues in experimental atherosclerosis] |
|
Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients. |
|
Prevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine. |
|
[Effect of trimethylglycine on lipid metabolism in experimental atherosclerosis in rabbits] |
|
Amelioration of ethionine toxicity in the chick. |
|
Effects of betaine on seizures in the rat. |
|
Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism |
|
Characterization of betaine efflux from rat liver mitochondria |
|
Metabolism of S-adenosylmethionine in rat hepatocytes: Transfer of methyl group from S-adenosylmethionine by methyltransferase reactions |
|
Effect of cobalamin inactivation on folate-dependent transformylases involved in purine synthesis in rats |
|
Labile methyl group balances in the human: The role of sarcosine |
|
Changes in plasma glucose and liver glycogen following the administration of gluconeogenic precursors to the starving fowl |
|
Effect of exogenous proline, betaine, and carnitine on growth of Listeria monocytogenes in a minimal medium |
|
Betaine:homocysteine methyltransferase - A new assay for the liver enzyme and its absence from human skin fibroblasts and peripheral blood lymphocytes |
|
Antimicrobial activity of betaine esters, quaternary ammonium amphiphiles which spontaneously hydrolyze into nontoxic components |
|
Cardiovascular risk factors in the older adult |
|
S-nitrosation ameliorates homocysteine-mediated neurotoxicity in primary culture of rat cortical neurons |
|
Hyperhomocystinemia threatens patients with kidney failure. Are intravenously administered high dosed vitamins effective? |
|
Homocystinuria: What about mild hyperhomocysteinaemia? |
|
Plasma homocyst(e)ine levels and graded risk for myocardial infarction: Findings in two populations at contrasting risk for coronary heart disease |
|
Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein |
|
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: A matched case-control study |
|
Prevalence of familial mild hyperhomocysteinemia |
|
Thrombosis and systemic lupus erythematosus: The hopkins lupus cohort perspective |
|
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects |
|
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia |
|
Hyperhomocysteinemia induced by folic acid deficiency and methionine load - Applications of a modified HPLC method |
|
Dietary methionine imbalance, endothelial cell dysfunction and atherosclerosis |
|
Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine |
|
Increased serum level of total homocysteine in CAPD patients: Despite fish oil therapy |
|
Hamocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium |
|
Homocysteine, folate, and vascular disease |
|
Ischemic heart disease |
|
Homocysteine and hemostasis: Pathogenetic mechanisms predisposing to Thrombosis |
|
Homocysteine and coronary atherosclerosis |
|
The effect of reduced glomerular filtration rate on plasma total homocysteine concentration |
|
Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients |
|
Homocysteine: Relation with ischemic vascular diseases |
|
Hyperhomocysteinemia: Background, diagnosis and treatment |
|
Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: A prospective, controlled analysis |
|
Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease |
|
High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients |
|
The influence of methionine and its metabolites on the progression of atherosclerosis in rabbits |
|
Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure |
|
Lipoproteins and homocyst(e)ine as risk factors for atherosclerosis: Assessment and treatment |
|
New aspects in lipidology and atherosclerosis |
|
Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell lineU-937) |
|
Prevention of myocardial infarction by vitamin B6 |
|
Vitamin B6: The overlooked key to preventing heart attacks |
|
New approaches to the prevention of atherosclerosis |
|
Role of folate in the modulation of lipids, lipoproteins and eicosanoids in hypertension and diabetes |
|
Hyperhomocysteinemia: An independent risk factor for atherosclerotic vascular disease |
|
Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients |
|
New aspects of risk factors for the development of atherosclerosis, including small low-density lipoprotein, homocyst(e)ine, and lipoprotein(a) |
|
Homocysteine and vascular disease |
|
Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: Initial results from the NHLBI family heart study |
|
Net uptake of plasma homocysteine by the rat kidney in vivo |
|
Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folate |
|
Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits |
|
Hyperhomocysteinaemia: A role in the accelerated atherogenesis of chronic renal failure? |
|
Plasma homocysteine in the acute and convalescent phases after stroke |
|
Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease |
|
Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia |
|
Hyperhomocysteiaemia and traditional cardiovascular disease risk factors in end-stage renal disease patients-on dialysis: A case-control study |
|
Hyperhomocysteinaemia in heart transplant recipients |
|
Homocyst(e)ine and arterial occlusive diseases |
|
Hyperhomocysteinemia |
|
Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen |
|
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis |
|
Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients |
|
Plasma homocyst(e)ine and arterial occlusive diseases: A mini-review |
|
Homocysteine and coronary artery disease |
|
Importance of elevated plasma homocysteine levels as a risk factor for atherosclerosis |
|
Relationship between homocysteine and cardiovascular risk factors in obesity |
|
A prospective study of plasma homocyst(e)ine and risk of ischemic stroke |
|
Arterial disease in hyperhomocysteinaemia and the effect of treatment: A pilot study |
|
Impaired homocysteine metabolism: A risk factor in young adults with atherosclerotic arterial occlusive disease of the leg |
|
Hyperhomocysteinaemia: A significant risk factor for cardiovascular disease in renal transplant recipients |
|
Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis |
|
Homocysteine, atherosclerosis and arterial thrombosis |
|
Oxidation of low densiy lipoprotein by thiols: Superoxide-dependent and independent mechanisms |
|
Chemical pathology of homocysteine I. Atherogenesis |
|
Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50 - Effect of smoking and extent of disease |
|
Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients |
|
Betaine effects on hepatic methionine metabolism elicited by short-term ethanol feeding |
|
Hepatic betaine-homocysteine methyltransferase activity in the chicken is influenced by dietary intake of sulfur amino acids, choline and betaine |
|
Homocystinuria: What about mild hyperhomocysteinaemia? |
|
Purification, kinetic properties, and cDNA cloning of mammalian betaine- homocysteine methyltransferase |
|
Betaine, ethanol, and the liver: A review |
|
Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient |
|
Human homocysteine catabolism: Three major pathways and their relevance to development of arterial occlusive disease |
|
Treatment of hyperhomocyst(e)inemia: Physiological basis |
|
Plasma homocyst(e)ine: A risk factor for arterial occlusive diseases |
|
Long term treatment with betaine in methylenetetrahydrofolate reductase deficiency |
|
Atypical hemolytic uremic syndrome due to an intracellular abnormality in vitamin B12 metabolism |
|
Homocysteine and vascular disease |
|
Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: The mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency |
|
Measurement of homocyst(e)ine in the prediction of arteriosclerosis |
|
Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia |
|
Plasma homocyst(e)ine and arterial occlusive diseases: A mini-review |
|
Hyperhomocysteinaemia: A newly recognized risk factor for vascular disease |
|
Therapeutical control of homocystinuria by means of the determination of total homocysteine in plasma |
|
Treatment of mild hyperhomocysteinemia in vascular disease patients |
|
Methylenetetrahydrofolate reductase deficiency: Prenatal diagnosis and family studies |
|
Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism |
|
Glycerophosphocholine and phosphocholine are the major choline metabolites in rat milk |